---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-084023"
form_type: "8-K/A"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:08:32.044086+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics to effect 1-for-10 reverse stock split effective July 17, 2024

## Summary
- Reverse split at 1-for-10 ratio; effective 5:00 p.m. Eastern on July 17, 2024.
- Stock will trade split-adjusted on Nasdaq under symbol 'TCRT' starting July 18, 2024 with new CUSIP 98973P309.
- Stockholder approval obtained at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
- Equiniti Trust Company appointed as exchange agent to handle share conversion.

## SEC filing metadata
- accession: 0000950170-24-084023
- form_type: 8-K/A
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/0000950170-24-084023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017024084023/tcrt-20240716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-084023
- JSON: https://secwatch.observer/filing/0000950170-24-084023.json
- Plain text: https://secwatch.observer/filing/0000950170-24-084023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.